Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 56 years ago
193K views
Shared 56 years ago
583 views
Shared 56 years ago
122 views
Shared 56 years ago
296 views
Shared 56 years ago
109 views
Shared 56 years ago
189 views
Shared 56 years ago
161K views
Shared 56 years ago
476 views
Shared 56 years ago
155 views
Shared 56 years ago
426K views
Shared 56 years ago
46K views
Shared 56 years ago
130K views
Shared 56 years ago
213K views
Shared 56 years ago
270K views
Shared 56 years ago
114K views
Shared 56 years ago
63 views
Shared 56 years ago
241 views
Shared 56 years ago
128 views
Shared 56 years ago
142 views
Shared 56 years ago
373 views
Shared 56 years ago
281 views